NCT01071278已完成不适用
Lipid Management in Clinical Practice
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,390
- 主要终点
- Number of Participants With Lipid Panel Control
研究概览
简要总结
The aim of this observational program is to generate data on the use of Tredaptive (nicotinic acid/laropiprant) for lipid management under routine medical practice conditions.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients are 18 years of age or older with lipid disorder treated with nicotinic acid/laropiprant
排除标准
- •Patient is currently participating in a clinical trial
结局指标
主要结局
Number of Participants With Lipid Panel Control
时间窗: From Visit 1 entrance evaluation (Week 0) to Visit 2 (between Weeks 8-22)
Lipid Panel Control was defined as achieving target for one or more of the following parameters: low-density lipoprotein cholesterol (LDL-C) at goal (\<100mg/dL), high-density lipoprotein cholesterol (HDL-C) within normal range (40mg/dL for males and 50mg/dL for females), and/or triglycerides within normal range (≤ 150mg/dL).
次要结局
- Number of Participants Who Reported Adverse Events(Up to 22 weeks)
研究者
相似试验
终止
4 期
Fatty Liver Study in Patients With Type II DiabetesNonalcoholic Fatty LiverType II DiabetesNCT02365233The University of Texas Medical Branch, Galveston5
进行中（未招募）
不适用
Extreme Lipids RepositoryLipoprotein DisorderNCT04156997University of Texas Southwestern Medical Center250
已完成
不适用
From Research to Practice - Lipid Management for Low HDL-CholesterolCoronary Heart DiseasePhysicians' Practice PatternsNCT00057044US Department of Veterans Affairs11,700
尚未招募
不适用
A Prospective, Open, Self-controlled Study of the Effects of Chiglitazar Sodium on Glucose and Lipid Metabolism in Patients With Type 2 Diabetes Mellitus (T2DM)DiabetesNCT06191328Yufan Wang40
终止
不适用
Lipid-lowering Therapy for Secondary Prevention in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)Coronary Artery DiseaseNCT01190072AstraZeneca120